Verily

By Jonah Comstock January 26, 2017
Verily, the Alphabet subsidiary formerly known as Google Life Sciences, raised $800 million in funding today from Temasek, a Singapore-based investment company. Temasek will take a minority stake in the company and nominate a member to the company's board. “Temasek has a history of thoughtful and enduring capital investments, including in life sciences and healthcare, and this commitment to a...
By Heather Mack December 5, 2016
Verily -- the Alphabet spinoff formerly known as Google Life Sciences -- has launched a new smart spoon that recognizes uncontrollable or unsteady hand movements at all times and automatically compensates, enabling people to eat without spilling. The robotic device, Liftware Level, is the second offering from Liftware, a company devoted to developing tools to aid those with motor impairments that...
By Jonah Comstock September 22, 2016
These days, it seems like the digital health world runs increasingly on partnerships. Last week, representatives from three tech companies famous for their partnerships — IBM Watson Health, Qualcomm Life, and Verily Life Sciences (formerly Google X Life Sciences — shared the stage at the Digital Medicine Connect conference in Boston to talk about what makes a good collaboration work. “I think at...
By Heather Mack September 12, 2016
Verily Life Sciences, a division of Google parent company Alphabet, has teamed up with French healthcare company Sanofi to launch Onduo, a diabetes-focused collaboration that leverages Sanofi’s pharmaceutical expertise and Verily’s command of miniaturized electronics, analytics and consumer software development. The two companies together invested about $500 million in Onduo. The joint venture is...
By Jonah Comstock August 3, 2016
Dexcom’s biggest triumph and its biggest let down this quarter both involved the FDA. On the positive side, a verdict from a special FDA panel means Dexcom may soon be able to change its CGM’s intended use to replace fingerstick glucometers. On the negative side, a voluntary device recall this quarter that potentially affected all of Dexcom’s receivers led to higher-than-expected Q2 losses....
By Heather Mack August 2, 2016
UK-based pharmaceutical giant GlaxoSmithKline has partnered with South San Francisco-based Verily to create Galvani Bioelectronics – a joint venture to develop implantable bioelectric medicines, a branch of medicine that works to fight diseases by targeting electrical signals in the body. Galvani, owned 55 percent by GSK and 45 percent by Verily (formerly known as Google Life Sciences) will have...
By Jonah Comstock June 1, 2016
Medella Health, the company whose founding team includes a Thiel Fellow and is racing Google and Novartis to develop a glucose-sensing contact lens, has raised $1.4 million in funding. Backers include 1517 Fund, Fifty Years Fund, Garage Capital, BDC Capital and others.  Not too much is known yet about Medella's lens. The company says it will integrate a small sensor, a chip, and a micro-antenna...
By Jonah Comstock March 28, 2016
Two health-related Google logos that recently appeared in the US Patent and Trademark Office's database are not for a resurrected Google Health or for a forthcoming product, but are instead the logos of Google acquisition DeepMind Health and its first app, Streams. SlashGear first spotted that the company had filed trademarks for two new health-related logos and speculated as to whether it...
By Aditi Pai February 25, 2016
This summer, National Institutes of Health (NIH) will launch a Participant Technologies Center to test and maintain connected sensor technologies as part of the White House’s Precision Medicine Initiative (PMI), NIH Director Francis Collins announced today at the Precision Medicine Summit. Vanderbilt University, with help from Verily (formerly known as Google Live Sciences) as advisors, will...
By Jonah Comstock January 11, 2016
Google has filed another interesting healthcare-related patent, a mechanism that could detect when a patient is eating and issue a contextual reminder to take a medication.  Israel-based patent authors Asaf Zomet and Michael Shynar describe the patented invention as one that uses some mechanism to detect when the user is eating, confirms that this is the case, and then delivers “a reminder to...